Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

LEENOS CORP to acquire equity shares of Dreamcis

Thursday, 16 Jan 2014 09:35pm EST 

LEENOS CORP:Says to acquire a 70.00 pct stake (70,415 shares) in Dreamcis, which is engaged in the provision of clinical trial agent service, for business diversification.Says transaction amount of 13,110,568,850 won.Says expected transaction settlement date of Feb. 14. 

Company Quote

-130.0 -3.51%
6 May 2015